Document Detail

Recent advances in cardiology.
MedLine Citation:
PMID:  20014984     Owner:  NLM     Status:  MEDLINE    
During 2009, multiple major cardiology trials have been presented or published. In this paper, we summarize and place in clinical context the new trial findings regarding anticoagulation (dabigatran), antiplatelet therapy (ticagrelor, clopidogrel, prasugrel and aspirin), percutaneous coronary management (thrombectomy, multivessel/left main disease and biodegradable polymers), medical therapy for coronary disease (ivabradine and rosuvastatin) and management of heart failure (beta-blocker strategy, atrial fibrillation and resynchronization therapy).
Ian A Menown; James A Shand
Related Documents :
17489664 - Enoxaparin in acute coronary syndromes.
8140884 - Secondary prevention of stroke: does dipyridamole add to aspirin?
12357514 - Feasibility and efficacy of transradial access for coronary interventions in patients w...
8106894 - The use of aspirin in cardiovascular disease.
761324 - Evidence from a nonrandomized study that coronary surgery prolongs survival in patients...
15348554 - Physicochemical and microscopical study of calcific deposits from natural and bioprosth...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Future cardiology     Volume:  6     ISSN:  1744-8298     ISO Abbreviation:  Future Cardiol     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2009-12-17     Completed Date:  2010-03-22     Revised Date:  2012-01-30    
Medline Journal Info:
Nlm Unique ID:  101239345     Medline TA:  Future Cardiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  11-7     Citation Subset:  IM    
Craigavon Cardiac Centre, Southern Trust, Northern Ireland, BT63 5QQ, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use
Angioplasty, Balloon, Coronary / trends
Anticoagulants / administration & dosage,  therapeutic use
Aspirin / therapeutic use
Cardiac Pacing, Artificial
Cardiology / trends*
Coronary Artery Disease / drug therapy*,  surgery,  therapy
Drug-Eluting Stents
Evidence-Based Medicine
Heart Failure / drug therapy*,  surgery,  therapy
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Platelet Aggregation Inhibitors / therapeutic use
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Anticoagulants; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin
Erratum In:
Future Cardiol. 2012 Jan;8(1):141-2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Sch...
Next Document:  Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.